Topical effect of Probiotic formulation on Streptococcus mutans counts in childre
Phase 4
Completed
- Registration Number
- CTRI/2019/09/021205
- Lead Sponsor
- STES Sinhgad dental college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Healthy Children with dmft/DMFT score 2-5
Exclusion Criteria
Free from systemic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms do probiotic strains in CTRI/2019/09/021205 use to inhibit Streptococcus mutans in children?
How does the efficacy of CTRI/2019/09/021205 probiotic formulation compare to chlorhexidine in reducing S. mutans in pediatric plaque?
Which biomarkers in 7-12 year old children correlate with response to probiotic S. mutans reduction in CTRI/2019/09/021205?
What are the safety profiles and adverse event management strategies for CTRI/2019/09/021205 probiotic formulation in pediatric patients?
What combination therapies with CTRI/2019/09/021205 probiotics enhance S. mutans suppression in pediatric dentistry?